Drug Discovery

NXP800: A New Hope for Hormone-Resistant Prostate Cancer Treatments
Research & Development NXP800: A New Hope for Hormone-Resistant Prostate Cancer Treatments

Prostate cancer remains one of the most common cancers among men, and while hormone therapies have significantly improved patient outcomes, resistance to these treatments is a major challenge. The emergence of NXP800, a novel drug currently under clinical trials, offers a promising new approach to

Genetic Discovery Could Revolutionize Pan-Cancer Metastasis Treatments
Research & Development Genetic Discovery Could Revolutionize Pan-Cancer Metastasis Treatments

A groundbreaking discovery in cancer research has unveiled a "genetic signature" involving 177 genes that are shared across multiple cancer types, fundamentally challenging prior assumptions about the mechanisms driving cancer metastasis. These findings open new avenues for innovative

NXP800: A New Hope in Combatting Advanced Prostate Cancer Treatment Resistance
Research & Development NXP800: A New Hope in Combatting Advanced Prostate Cancer Treatment Resistance

The fight against advanced prostate cancer has taken a promising turn with the development of a new drug, NXP800. This innovative treatment aims to help patients for whom current therapies have become ineffective. By specifically targeting the heat shock factor 1 (HSF1) pathway, NXP800 addresses

Can AI Transform Undruggable Targets in Cancer Treatment?
Research & Development Can AI Transform Undruggable Targets in Cancer Treatment?

The field of drug discovery has long been challenged by the concept of "undruggable" targets—proteins and pathways that are crucial in disease processes but difficult to target with traditional small molecule drugs. One particularly challenging target is β-catenin, a key player in the Wn

Insilico Medicine's AI-Driven Drug ISM5411 Shows Promise for Treating IBD
Tech & Innovation Insilico Medicine's AI-Driven Drug ISM5411 Shows Promise for Treating IBD

Insilico Medicine, a clinical-stage company leveraging generative artificial intelligence (AI) for drug discovery and development, has announced promising results for its novel drug, ISM5411, aimed at treating Inflammatory Bowel Disease (IBD). This gut-restricted and PHD-specific inhibitor was

How Will Clinical Trials Transform with Real World Data by 2025?
Research & Development How Will Clinical Trials Transform with Real World Data by 2025?

The landscape of clinical trials is on the brink of a significant transformation, driven by the integration of Real World Data (RWD). By 2025, the use of RWD is expected to revolutionize the way clinical trials are conducted, offering new opportunities for efficiency, accuracy, and patient-centric

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later